Skip to main content

Table 3 Antiplatelet/anticoagulation therapy

From: Primary percutaneous coronary intervention in nonagenarians: is it worthwhile?

Variables PPCI patients (n = 42) MM patients (n = 69) P value
Anti-platelet agents
Aspirin only 0 (0) 9 (13.0) 0.013
Aspirin + Clopidogrel 10 (23.8) 32 (46.4) 0.017
Aspirin + Ticagrelor 31 (73.8) 15 (21.7)  < 0.001
Clopidogrel only 1 (2.4) 6 (8.7) 0.25
Anticoagulation agent
Warfarin 1 (2.4) 2 (2.9)  > 0.99
Direct oral anti-coagulation 3 (7.1) 4 (5.8)  > 0.99
Combination therapy
Clopidogrel + Anticoagulation 0 (0) 2 (2.9) 0.53
Triple therapy 4 (9.5) 4 (5.8) 0.47
  1. Values in bold demonstrate statistically significant results (p < 0.05)
  2. PPCI primary percutaneous coronary intervention, MM medically managed, Triple therapy aspirin + clopidogrel + anticoagulation
  3. Values in brackets are (%)